We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.60 | 3.55% | 17.50 | 16.90 | 18.10 | 17,784 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 13.36 | 4.6B |
From Apr 2019 to Apr 2024
TIDMGLB
RNS Number : 5532F
Glanbia PLC
21 February 2018
Glanbia plc
2017 Annual Report and Financial Statements
21 February 2018 Glanbia plc announces that it has today published and released to the media electronic versions of its 2017 Annual Report and Financial Statements for the year ended 30 December 2017 on its website.
To download the 2017 Annual Report and Financial Statements- please go to:
www.glanbia.com/report
A copy of the 2017 Annual Report and Financial Statements for the year ended 30 December 2017 has been submitted to the Irish Stock Exchange and the UK National Storage Mechanism.
The document will shortly be available for inspection at:
Companies Announcements Office,
Irish Stock Exchange,
28 Anglesea Street,
Dublin 2,
Ireland
and
http://www.morningstar.co.uk/uk/NSM
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSLLFVVFAILFIT
(END) Dow Jones Newswires
February 21, 2018 08:41 ET (13:41 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
